BIOREGENX, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOREGENX, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $23.57K.
- BIOREGENX, INC. stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $314.90K, a 269.27% increase year-over-year.
- BIOREGENX, INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $8.57K, a 87.37% decline year-over-year.
- BIOREGENX, INC. stock issued during period, value, issued for services for the quarter ending 2024-12-31 was $85.28K.
- BIOREGENX, INC. stock issued during period, value, issued for services for fiscal 2025 was $350.35K, a 58.42% decline from fiscal 2024.
- BIOREGENX, INC. stock issued during period, value, issued for services for fiscal 2024 was $842.68K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $23.57K 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $314.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $350.35K 10-K · filed 2026-04-15 |
| 2025-09-30 | $8.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | |
| 2024-12-31 | $85.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $842.68K 10-K · filed 2026-04-15 |
| 2024-09-30 | $67.83K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $67.83K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $621.74K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $400.60K 10-Q/A · filed 2024-05-29 | |
| 2023-03-31 | $81.60K 10-Q · filed 2023-11-20 |